This conclusion is supported by data showing that many cancer cells with no detectable p53 transcriptional activity, such as breast cancer cells and HaCaT cells, which carry mutations in both alleles of p53 (R282W and H179Y) that render the protein transcriptionally inactive, express high levels of galectin-7 [17,20]. This evidence concerns the gene TP53 and cancer.